Nae-Yuh Wang

Nae-Yuh Wang

Auto-generated profile, based on publicly available information

Nae-Yuh Wang

Departments of Medicine, Biostatistics, and Epidemiology, Johns Hopkins University, Baltimore, MD (N.-Y.W.).

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2010 in JAMA
Verified
Journal Article
Open access
PDF file
JNJohn K. Niparko
John K. Niparko
ETEmily A. Tobey
Emily A. Tobey
DTDonna J. Thal
Donna J. Thal
LELaurie S. Eisenberg
Laurie S. Eisenberg
NWNae-Yuh Wang
Nae-Yuh Wang
NFNancy E. Fink
Nancy E. Fink
Young children who experience severe to profound sensorineural hearing loss (SNHL) face challenges in developing spoken language because of an inability to detect acoustic-phonetic cues that are essential for speech recognition, even when fitted with traditional amplification devices (hearing aids). More than half of such children are treated with cochlear implantation.1 Cochlear implant systems comprise an externally worn microphone and a microprocessor programmed to extract intensity, frequency, and timing cues from acoustic signals. The system transforms these acoustic cues into an electrical code. Internally, a surgically placed receiver relays the transmitted code to an implanted array of contacts in the cochlea to stimulate surviving auditory neurons.2 With experience, children understand speech, environmental sounds, and music with varying degrees of success.3-6

24 November 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
LALawrence Appel
Lawrence Appel
JCJeanne M. Clark
Jeanne M. Clark
HYHsin-Chieh Yeh
Hsin-Chieh Yeh
NWNae-Yuh Wang
Nae-Yuh Wang
JCJanelle W. Coughlin
Janelle W. Coughlin
FBFrederick L. Brancati
Frederick L. Brancati
Obesity and its cardiovascular complications are extremely common medical problems, but evidence on how to accomplish weight loss in clinical practice is sparse. We conducted a randomized, controlled trial to examine the effects of two behavioral weight-loss interventions in 415 obese patients with at least one cardiovascular risk factor. Participants were recruited from six primary care practices; 63.6% were women, 41.0% were black, and the mean age was 54.0 years. One intervention provided patients with weight-loss support remotely — through the telephone, a study-specific Web site, and e-mail. The other intervention provided in-person support during group and individual sessions, along with the three remote means of support. There was also a control group in which weight loss was self-directed. Outcomes were compared between each intervention group and the control group and between the two intervention groups. For both interventions, primary care providers reinforced participation at routinely scheduled visits. The trial duration was 24 months. At baseline, the mean body-mass index (the weight in kilograms divided by the square of the height in meters) for all participants was 36.6, and the mean weight was 103.8 kg. At 24 months, the mean change in weight from baseline was −0.8 kg in the control group, −4.6 kg in the group receiving remote support only (P<0.001 for the comparison with the control group), and −5.1 kg in the group receiving in-person support (P<0.001 for the comparison with the control group). The percentage of participants who lost 5% or more of their initial weight was 18.8% in the control group, 38.2% in the group receiving remote support only, and 41.4% in the group receiving in-person support. The change in weight from baseline did not differ significantly between the two intervention groups. In two behavioral interventions, one delivered with in-person support and the other delivered remotely, without face-to-face contact between participants and weight-loss coaches, obese patients achieved and sustained clinically significant weight loss over a period of 24 months. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00783315.)

5 September 2000 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
AGAllan C. Gelber
Allan C. Gelber
MHMarc C. Hochberg
Marc C. Hochberg
LMLucy A. Mead
Lucy A. Mead
NWNae-Yuh Wang
Nae-Yuh Wang
FWFredrick M. Wigley
Fredrick M. Wigley
MKMichael J. Klag
Michael J. Klag
Knee and hip injuries have been linked with osteoarthritis in cross-sectional and case–control studies, but few prospective studies have examined the relation between injuries in young adults and risk for later osteoarthritis. To prospectively examine the relation between joint injury and incident knee and hip osteoarthritis. Prospective cohort study. Johns Hopkins Precursors Study. 1321 former medical students. Injury status at cohort entry was recorded when the mean age of participants was 22 years. Injury during follow-up and incident osteoarthritis were determined by using self-administered questionnaires. Osteoarthritis was confirmed by symptoms and radiographic findings. Over a median follow-up of 36 years, 141 participants reported joint injuries (knee alone [n = 111], hip alone [n = 16], or knee and hip [n = 14]) and 96 developed osteoarthritis (knee alone [n = 64], hip alone [n = 27], or knee and hip [n = 5]). The cumulative incidence of knee osteoarthritis by 65 years of age was 13.9% in participants who had a knee injury during adolescence and young adulthood and 6.0% in those who did not (P = 0.0045) (relative risk, 2.95 [95% CI, 1.35 to 6.45]). Joint injury at cohort entry or during follow-up substantially increased the risk for subsequent osteoarthritis at that site (relative risk, 5.17 [CI, 3.07 to 8.71] and 3.50 [CI, 0.84 to 14.69] for knee and hip, respectively). Results were similar for persons with osteoarthritis confirmed by radiographs and symptoms. Young adults with knee injuries are at considerably increased risk for osteoarthritis later in life and should be targeted in the primary prevention of osteoarthritis.

1 April 2003 in Medical Care
Verified
Journal Article
Closed access
LCLisa A. Cooper
Lisa A. Cooper
JGJunius J. Gonzales
Junius J. Gonzales
JGJoseph J. Gallo
Joseph J. Gallo
KRKathryn M. Rost
Kathryn M. Rost
LMLisa S. Meredith
Lisa S. Meredith
DFDaniel E. Ford
Daniel E. Ford
Ethnic minority patients are less likely than white patients to receive guideline-concordant care for depression. It is uncertain whether racial and ethnic differences exist in patient beliefs, attitudes, and preferences for treatment. A telephone survey was conducted of 829 adult patients (659 non-Hispanic whites, 97 African Americans, 73 Hispanics) recruited from primary care offices across the United States who reported 1 week or more of depressed mood or loss of interest within the past month and who met criteria for Major Depressive Episode in the past year. Within this cohort, we examined differences among African Americans, Hispanics, and whites in acceptability of antidepressant medication and acceptability of individual counseling. African Americans (adjusted OR, 0.30; 95% CI 0.19-0.48) and Hispanics (adjusted OR, 0.44; 95% CI, 0.26-0.76) had lower odds than white persons of finding antidepressant medications acceptable. African Americans had somewhat lower odds (adjusted OR, 0.63; 95% CI, 0.35-1.12), and Hispanics had higher odds (adjusted OR, 3.26; 95% CI, 1.08-9.89) of finding counseling acceptable than white persons. Some negative beliefs regarding treatment were more prevalent among ethnic minorities; however adjustment for these beliefs did not explain differences in acceptability of treatment for depression. African Americans are less likely than white persons to find antidepressant medication acceptable. Hispanics are less likely to find antidepressant medication acceptable, and more likely to find counseling acceptable than white persons. Racial and ethnic differences in beliefs about treatment modalities were found, but did not explain differences in the acceptability of depression treatment. Clinicians should consider patients' cultural and social context when negotiating treatment decisions for depression. Future research should identify other attitudinal barriers to depression care among ethnic minority patients.

25 April 2013 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
GDGail L. Daumit
Gail L. Daumit
FDFaith B. Dickerson
Faith B. Dickerson
NWNae-Yuh Wang
Nae-Yuh Wang
ADArlene Dalcin
Arlene Dalcin
GJGerald Jerome
Gerald Jerome
LALawrence J. Appel
Lawrence J. Appel
Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness. We recruited overweight or obese adults from 10 community psychiatric rehabilitation outpatient programs and randomly assigned them to an intervention or a control group. Participants in the intervention group received tailored group and individual weight-management sessions and group exercise sessions. Weight change was assessed at 6, 12, and 18 months. Of 291 participants who underwent randomization, 58.1% had schizophrenia or a schizoaffective disorder, 22.0% had bipolar disorder, and 12.0% had major depression. At baseline, the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 36.3, and the mean weight was 102.7 kg (225.9 lb). Data on weight at 18 months were obtained from 279 participants. Weight loss in the intervention group increased progressively over the 18-month study period and differed significantly from the control group at each follow-up visit. At 18 months, the mean between-group difference in weight (change in intervention group minus change in control group) was −3.2 kg (−7.0 lb, P=0.002); 37.8% of the participants in the intervention group lost 5% or more of their initial weight, as compared with 22.7% of those in the control group (P=0.009). There were no significant between-group differences in adverse events. A behavioral weight-loss intervention significantly reduced weight over a period of 18 months in overweight and obese adults with serious mental illness. Given the epidemic of obesity and weight-related disease among persons with serious mental illness, our findings support implementation of targeted behavioral weight-loss interventions in this high-risk population. (Funded by the National Institute of Mental Health; ACHIEVE ClinicalTrials.gov number, NCT00902694.)

13 July 1998 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
DFDaniel E. Ford
Daniel E. Ford
LMLucy A. Mead
Lucy A. Mead
PCPatricia P. Chang
Patricia P. Chang
LCLisa Cooper-Patrick
Lisa Cooper-Patrick
NWNae-Yuh Wang
Nae-Yuh Wang
MKMichael J. Klag
Michael J. Klag
SEVERAL LINES of evidence suggest that clinical depression may be a risk factor for coronary artery disease (CAD). In patients with known CAD, depression predicts long-term mortality.1-3 In prospective studies in which c socioeconomic status, traditional cardiovascular risk factors, and preexisting heart disease were controlled for, depressed affect and hopelessness were independent risk factors for fatal and nonfatal CAD.4,5 Increasing level of depression over time, but not extent of baseline depressive symptoms, was a predictor for cardiovascular events in a sample of older adults participating in a clinical trial.6 Depressive symptoms were associated with incident CAD in a sample of elderly Danish men and women.7 However, several studies have not found an association between depression and incident CAD.8,9